Literature DB >> 26220833

Introduction to special issue on glaucomatous optic neuropathy: In vivo models and techniques.

C Ross Ethier1, John C Morrison2, Abbott F Clark3.   

Abstract

Entities:  

Keywords:  Animal models; Glaucoma; Optic nerve; Techniques

Mesh：

Year:  2015        PMID： 26220833      PMCID： PMC4628876          DOI： 10.1016/j.exer.2015.07.017

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN： 0014-4835            Impact factor:   3.467


× No keyword cloud information.
  9 in total

1.  The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration.The AGIS Investigators.

Authors: 
Journal:  Am J Ophthalmol       Date:  2000-10       Impact factor: 5.258

Review 2.  Primary open-angle glaucoma.

Authors:  Robert N Weinreb; Peng Tee Khaw
Journal:  Lancet       Date:  2004-05-22       Impact factor: 79.321

3.  Natural history of normal-tension glaucoma.

Authors:  D R Anderson; S M Drance; M Schulzer
Journal:  Ophthalmology       Date:  2001-02       Impact factor: 12.079

4.  The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma.

Authors:  Michael A Kass; Dale K Heuer; Eve J Higginbotham; Chris A Johnson; John L Keltner; J Philip Miller; Richard K Parrish; M Roy Wilson; Mae O Gordon
Journal:  Arch Ophthalmol       Date:  2002-06

5.  A long-term prospective study of risk factors for glaucomatous visual field loss in patients with ocular hypertension.

Authors:  Boel Bengtsson; Anders Heijl
Journal:  J Glaucoma       Date:  2005-04       Impact factor: 2.503

6.  Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial.

Authors:  Anders Heijl; M Cristina Leske; Bo Bengtsson; Leslie Hyman; Boel Bengtsson; Mohamed Hussein
Journal:  Arch Ophthalmol       Date:  2002-10

Review 7.  Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis.

Authors:  Yih-Chung Tham; Xiang Li; Tien Y Wong; Harry A Quigley; Tin Aung; Ching-Yu Cheng
Journal:  Ophthalmology       Date:  2014-06-26       Impact factor: 12.079

8.  A long-term clinical trial of timolol therapy versus no treatment in the management of glaucoma suspects.

Authors:  D L Epstein; J H Krug; E Hertzmark; L L Remis; D J Edelstein
Journal:  Ophthalmology       Date:  1989-10       Impact factor: 12.079

9.  Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial.

Authors:  M Cristina Leske; Anders Heijl; Mohamed Hussein; Bo Bengtsson; Leslie Hyman; Eugene Komaroff
Journal:  Arch Ophthalmol       Date:  2003-01
  9 in total
  1 in total

Review 1.  Biomechanical aspects of axonal damage in glaucoma: A brief review.

Authors:  Cheri Stowell; Claude F Burgoyne; Ernst R Tamm; C Ross Ethier
Journal:  Exp Eye Res       Date:  2017-02-20       Impact factor: 3.467
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.